Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
60 participants
INTERVENTIONAL
2012-11-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
NCT06549023
Loss to Follow-up in PDR Patients
NCT04018326
Comparison of Two Laser Therapy Methods for PDR
NCT01232179
Panretinal Photocoagulation During Vitrectomy for Diabetic Vitreous Hemorrhage
NCT05318742
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
NCT01023698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-fluence
Low-fluence pan-retinal photocoagulation in a single session for proliferative diabetic retinopathy
Low-fluence PRP with 532nm green LASER
To administer low-fluence PRP in a single session for PDR
Full-fluence
Full-fluence pan-retinal photocoagulation for proliferative diabetic retinopathy
Full-Fluence PRP with 532nm LASER
To administer full-fluence PRP in two sessions for PDR
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-fluence PRP with 532nm green LASER
To administer low-fluence PRP in a single session for PDR
Full-Fluence PRP with 532nm LASER
To administer full-fluence PRP in two sessions for PDR
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Proliferative diabetic retinopathy
Exclusion Criteria
* Media opacities
* Previous treatment for macular edema (LASER or intravitreal injections)
* Recent (less than 6 months) ophthalmic surgery
* Only eyes
* Intra-retinal or sub-retinal fluid with foveal involvement
* Chronic renal failure
* History of liver or pancreatic transplant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación para Evitar la Ceguera en México
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillermo Salcedo-Villanueva, MD
Role: PRINCIPAL_INVESTIGATOR
Asociación para Evitar la Ceguera en México
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asociación Para Evitar la Ceguera en México
Mexico City, Mexico City, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APEC-LFPRP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.